Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Daniel Brungs"'
Autor:
Pasi A. Jänne, Li Zheng, Wei-Hsun Hsu, Yan Xu, Bo Gao, Chee Khoon Lee, Lyudmila Bazhenova, Daniel Brungs, Liyan Jiang, Ying Cheng, Wen-Tsung Huang, Yun Fan, Michael Millward, Viola W. Zhu, Tsung-Ying Yang, Wu-Chou Su, Yanqiu Zhao, Jianying Zhou, Chao-Hua Chiu, Weiqi Nian, D. Ross Camidge, Jian Fang, Paul L. Mitchell, James Chih-Hsin Yang, Mengzhao Wang
Supplementary Figure from Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non–Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4880c1f3414b8ccc710eceb5f2e4b312
https://doi.org/10.1158/2159-8290.22541200
https://doi.org/10.1158/2159-8290.22541200
Autor:
Pasi A. Jänne, Li Zheng, Wei-Hsun Hsu, Yan Xu, Bo Gao, Chee Khoon Lee, Lyudmila Bazhenova, Daniel Brungs, Liyan Jiang, Ying Cheng, Wen-Tsung Huang, Yun Fan, Michael Millward, Viola W. Zhu, Tsung-Ying Yang, Wu-Chou Su, Yanqiu Zhao, Jianying Zhou, Chao-Hua Chiu, Weiqi Nian, D. Ross Camidge, Jian Fang, Paul L. Mitchell, James Chih-Hsin Yang, Mengzhao Wang
Supplementary Data from Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non–Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c20995c99deeceb3f621304402b4499
https://doi.org/10.1158/2159-8290.22541203.v1
https://doi.org/10.1158/2159-8290.22541203.v1
Autor:
Pasi A. Jänne, Li Zheng, Wei-Hsun Hsu, Yan Xu, Bo Gao, Chee Khoon Lee, Lyudmila Bazhenova, Daniel Brungs, Liyan Jiang, Ying Cheng, Wen-Tsung Huang, Yun Fan, Michael Millward, Viola W. Zhu, Tsung-Ying Yang, Wu-Chou Su, Yanqiu Zhao, Jianying Zhou, Chao-Hua Chiu, Weiqi Nian, D. Ross Camidge, Jian Fang, Paul L. Mitchell, James Chih-Hsin Yang, Mengzhao Wang
Epidermal growth factor receptor exon 20 insertion mutations (EGFRexon20ins) are detected in approximately 2% of patients with non–small cell lung cancer (NSCLC). Due to a lack of effective therapy, the prognosis of these patients is typically poor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9733d96ae0fbaf455a4520a8582283b4
https://doi.org/10.1158/2159-8290.c.6549568
https://doi.org/10.1158/2159-8290.c.6549568
Autor:
Pasi A. Jänne, Li Zheng, Wei-Hsun Hsu, Yan Xu, Bo Gao, Chee Khoon Lee, Lyudmila Bazhenova, Daniel Brungs, Liyan Jiang, Ying Cheng, Wen-Tsung Huang, Yun Fan, Michael Millward, Viola W. Zhu, Tsung-Ying Yang, Wu-Chou Su, Yanqiu Zhao, Jianying Zhou, Chao-Hua Chiu, Weiqi Nian, D. Ross Camidge, Jian Fang, Paul L. Mitchell, James Chih-Hsin Yang, Mengzhao Wang
Supplementary Table from Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non–Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0537d84bf01296b9b69eca1efcf97c96
https://doi.org/10.1158/2159-8290.22541197.v1
https://doi.org/10.1158/2159-8290.22541197.v1